Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Bromide, N-methylscopolamine
2. Dd 234
3. Dd-234
4. Dd234
5. Hyoscine Methiodide
6. Hyoscine Methobromide
7. Iodide, N-methylscopolamine
8. Methiodide, Hyoscine
9. Methobromide, Hyoscine
10. Methscopolamine
11. Methylbromide, Scopolamine
12. Methylchloride, N-methylscopolamine
13. Methylscopolamine Nitrate
14. Methylscopolammonium Methylsulfate
15. Methylsulfate, Methylscopolammonium
16. Methylsulfate, N-methylscine
17. Methylsulfate, N-methylscopolamine
18. N Methylscine Methylsulfate
19. N Methylscopolamine
20. N Methylscopolamine Bromide
21. N Methylscopolamine Iodide
22. N Methylscopolamine Methylchloride
23. N Methylscopolamine Methylsulfate
24. N Methylscopolamine Nitrate
25. N-methylscine Methylsulfate
26. N-methylscopolamine
27. N-methylscopolamine Bromide
28. N-methylscopolamine Iodide
29. N-methylscopolamine Methylchloride
30. N-methylscopolamine Methylsulfate
31. N-methylscopolamine Nitrate
32. Nitrate, Methylscopolamine
33. Nitrate, N-methylscopolamine
34. Scopolamine Methylbromide
35. Skopyl
36. Ulix
1. 155-41-9
2. Hyoscine Methyl Bromide
3. Scopolamine Methobromide
4. Holopon
5. Hyoscine Methobromide
6. Scopolamine Methyl Bromide
7. Scopolamine Methylbromide
8. (-)-scopolamine Methyl Bromide
9. Pamine
10. Methscopolamine (bromide)
11. Methylscopolamine Bromide
12. Epoxytropine Tropate Methylbromide
13. N-methylhyoscinium Bromide
14. Rtn51lk7wl
15. Proscomide
16. N-methylscopolamine Bromide
17. N-methylhyoscine Bromide
18. Mls000069754
19. Chembl3091667
20. Chebi:61276
21. N-methylscopolammonium Bromide
22. Ampyrox
23. Mescopil
24. Paraspan
25. Restropin
26. Blocan
27. Diopal
28. Nutrop
29. Nsc-120606
30. Neo-avagal
31. Lescopine Bromide
32. Smr000058794
33. (s)-6beta,7beta-epoxy-8-methyl-3alpha-(-)-tropoyloxy-1alphah,5alphah-tromanium Bromide
34. Dsstox_cid_20608
35. Dsstox_rid_79509
36. Dsstox_gsid_40608
37. Epoxymethamine Bromide
38. Hyoscine Methylbromide
39. Methscopolamine Bromide [usp]
40. Methoscopylamine Bromide
41. Scordin
42. Pamine Forte
43. Methylscopolamine Hydrobromide
44. Cas-155-41-9
45. Hyoscin Methobromide
46. Hyoscin-n-methylbromid
47. Scopolammonium, N-methylbromide
48. (-)-scopolamine Methobromide
49. Scopolamin-n-methylbromid
50. Unii-rtn51lk7wl
51. Mfcd00078560
52. Isobutylenesulfide
53. Scopolammonium, N-methyl-, Bromide
54. Einecs 205-844-5
55. Methylhyoscine Bromide
56. Nsc 120606
57. Opera_id_514
58. Methscopolamine (pamine)
59. Ncgc00013724-01
60. Ec 205-844-5
61. U 0382
62. Schembl152483
63. Chembl1354199
64. Dtxsid2040608
65. Hms2235k24
66. Hms3884g18
67. Hy-b0344
68. Methscopolamine Bromide [mi]
69. Tox21_110037
70. Bdbm50494458
71. S1978
72. Hyoscine Methobromide [mart.]
73. Hyoscine Methobromide [who-dd]
74. Tox21_110037_1
75. Ccg-268630
76. Ds-3286
77. Methscopolamine Bromide [vandf]
78. Scopolamine Methyl Bromide [mi]
79. 1alphah,5alphah-tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, Bromide, (-)-tropate
80. 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-1alphah,5alphah-tropanium Bromide (-)-tropate
81. Methscopolamine Bromide [usp-rs]
82. Ncgc00022697-03
83. 1-alpha-h,5-alpha-h-tropanium,6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, Bromide, (-)-tropate (ester)
84. 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxo-9-azoniatricyclo-(3.3.1.0(2,4))nonane Bromide
85. Methscopolamine Bromide [orange Book]
86. Sw219038-1
87. Methscopolamine Bromide [usp Monograph]
88. (-)-scopolamine Methyl Bromide, >=98% (hplc), Powder
89. Methscopolamine Bromide, United States Pharmacopeia (usp) Reference Standard
90. (-)-(1s,3s,5r,6r,7s)-6,7-epoxy-8-methyl-3-[(s)-tropoyloxy]tropanium Bromide
91. Oxitropium Bromide Impurity B, European Pharmacopoeia (ep) Reference Standard
92. (1r,2r,4s,5s,7s)-7-[[(2s)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide (methylhyoscine Bromide)
93. (1r,2r,4s,5s,7s)-7-[[(2s)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide
94. (1r,2r,4s,5s,7s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane
95. (1r,2r,4s,5s,7s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromidebromide
96. [(1r,2r,4s,5s)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2s)-3-hydroxy-2-phenylpropanoate;bromide
97. 1-alpha-h,5-alpha-h-tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, Bromide, (-)-tropate (ester)
98. 3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, Bromide, (7(s)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.))-
99. 3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, Bromide, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-
100. 3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2s)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, Bromide (1:1), (1alpha,2beta,4beta,5alpha,7beta)-
101. 3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2s)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, Bromide, (1alpha,2beta,4beta,5alpha,7beta)-
102. 3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2s)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, Bromide (1:1), (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-
103. 6.beta.,7.beta.-epoxy-3.alpha.-hydroxy-8-methyl-1.alpha.h,5.alpha.h-tropanium Bromide (-)-tropate
Molecular Weight | 398.3 g/mol |
---|---|
Molecular Formula | C18H24BrNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 397.08887 g/mol |
Monoisotopic Mass | 397.08887 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 454 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Methscopolamine bromide |
PubMed Health | Methscopolamine (By mouth) |
Drug Classes | Antiemetic, Antivertigo, Gastrointestinal Agent, Urinary Antispasmodic |
Drug Label | Methscopolamine Bromide Tablets USP, 2.5 mg and 5mg contain methscopolamine bromide, an anticholinergic, which occurs as white crystals, or as a white odorless crystalline powder. Methscopolamine bromide melts at about 225C with decomposition. The... |
Active Ingredient | Methscopolamine bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg |
Market Status | Prescription |
Company | Vintage Pharms; Breckenridge Pharm; Bayshore Pharms |
2 of 4 | |
---|---|
Drug Name | Pamine |
Active Ingredient | Methscopolamine bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg |
Market Status | Prescription |
Company | Fougera Pharms |
3 of 4 | |
---|---|
Drug Name | Methscopolamine bromide |
PubMed Health | Methscopolamine (By mouth) |
Drug Classes | Antiemetic, Antivertigo, Gastrointestinal Agent, Urinary Antispasmodic |
Drug Label | Methscopolamine Bromide Tablets USP, 2.5 mg and 5mg contain methscopolamine bromide, an anticholinergic, which occurs as white crystals, or as a white odorless crystalline powder. Methscopolamine bromide melts at about 225C with decomposition. The... |
Active Ingredient | Methscopolamine bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg |
Market Status | Prescription |
Company | Vintage Pharms; Breckenridge Pharm; Bayshore Pharms |
4 of 4 | |
---|---|
Drug Name | Pamine |
Active Ingredient | Methscopolamine bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg |
Market Status | Prescription |
Company | Fougera Pharms |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Methscopolamine Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methscopolamine Bromide, including repackagers and relabelers. The FDA regulates Methscopolamine Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methscopolamine Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methscopolamine Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methscopolamine Bromide supplier is an individual or a company that provides Methscopolamine Bromide active pharmaceutical ingredient (API) or Methscopolamine Bromide finished formulations upon request. The Methscopolamine Bromide suppliers may include Methscopolamine Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Methscopolamine Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Methscopolamine Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Methscopolamine Bromide active pharmaceutical ingredient (API) in detail. Different forms of Methscopolamine Bromide DMFs exist exist since differing nations have different regulations, such as Methscopolamine Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methscopolamine Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Methscopolamine Bromide USDMF includes data on Methscopolamine Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methscopolamine Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methscopolamine Bromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Methscopolamine Bromide Drug Master File in Japan (Methscopolamine Bromide JDMF) empowers Methscopolamine Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Methscopolamine Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Methscopolamine Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Methscopolamine Bromide suppliers with JDMF on PharmaCompass.
A Methscopolamine Bromide written confirmation (Methscopolamine Bromide WC) is an official document issued by a regulatory agency to a Methscopolamine Bromide manufacturer, verifying that the manufacturing facility of a Methscopolamine Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Methscopolamine Bromide APIs or Methscopolamine Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Methscopolamine Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Methscopolamine Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methscopolamine Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methscopolamine Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methscopolamine Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methscopolamine Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methscopolamine Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methscopolamine Bromide suppliers with NDC on PharmaCompass.
Methscopolamine Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methscopolamine Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methscopolamine Bromide GMP manufacturer or Methscopolamine Bromide GMP API supplier for your needs.
A Methscopolamine Bromide CoA (Certificate of Analysis) is a formal document that attests to Methscopolamine Bromide's compliance with Methscopolamine Bromide specifications and serves as a tool for batch-level quality control.
Methscopolamine Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Methscopolamine Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methscopolamine Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Methscopolamine Bromide EP), Methscopolamine Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methscopolamine Bromide USP).
LOOKING FOR A SUPPLIER?